METX and Q9T Related Headlines
Go Back- ME Therapeutics announces private placement to raise up to $500,000
- ME Therapeutics Announces Private Placement
- ME Therapeutics to Pitch at CSE Capital Tech Connect During Web Summit Vancouver
- ME Therapeutics Provides Scientific Update on In Vivo CAR and Therapeutic mRNA Programs
- ME Therapeutics Scientific and Corporate Update
- ME Therapeutics Attending JP Morgan Healthcare Conference
- ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell Therapy Program
- ME Therapeutics Added to CSE25 Index
- ME Therapeutics Secures U.S. Patent for Lead Candidate and Advances Broader Therapeutic Programs
METX and Q9T Related Press Releases
Go Back- ME Therapeutics Announces Private Placement
- ME Therapeutics to Pitch at CSE Capital Tech Connect During Web Summit Vancouver
- ME Therapeutics Provides Scientific Update on In Vivo CAR and Therapeutic mRNA Programs
- ME Therapeutics Scientific and Corporate Update
- ME Therapeutics Attending JP Morgan Healthcare Conference
- ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell Therapy Program
- ME Therapeutics Added to CSE25 Index
- ME Therapeutics Secures U.S. Patent for Lead Candidate and Advances Broader Therapeutic Programs
